Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Vaccitech plc
Vaccitech to Host KOL Webinar on Seeking a Functional Cure for Chronic Hepatitis B on September 20, 2023
September 13, 2023
From
Vaccitech plc
Via
GlobeNewswire
Tickers
VACC
Vaccitech Reports Second Quarter 2023 Financial Results and Recent Corporate Developments
August 10, 2023
From
Vaccitech plc
Via
GlobeNewswire
Tickers
VACC
Vaccitech to Present Positive Final Data at EASL Congress for Phase 1b/2 HBV002 Study in Adults with Chronic Hepatitis B
June 21, 2023
From
Vaccitech plc
Via
GlobeNewswire
Tickers
VACC
Vaccitech Doses First Patient in PCA001, a Prostate Cancer Phase 1/2 Clinical Trial of VTP-850 Immunotherapeutic Candidate in Men with Rising PSA after Definitive Local Therapy
June 12, 2023
From
Vaccitech plc
Via
GlobeNewswire
Tickers
VACC
Vaccitech Presents Interim Data from Phase 1b/2 Study of VTP-200 at 35th Annual International Papillomavirus Conference (IPVC) Highlighting Favorable Tolerability and Immunogenicity Profile
April 17, 2023
From
Vaccitech plc
Via
GlobeNewswire
Tickers
VACC
Vaccitech Announces Positive Topline Final Data for HBV002 Study in People with Chronic Hepatitis B
March 28, 2023
From
Vaccitech plc
Via
GlobeNewswire
Tickers
VACC
Vaccitech Reports Full-Year 2022 Financial Results and an Update on Corporate Developments
March 24, 2023
From
Vaccitech plc
Via
GlobeNewswire
Tickers
VACC
Vaccitech’s VTP-200 Ph 1b/2 Study Demonstrates Favorable Tolerability and Immunogenicity Profile at Interim Analysis in Women with Low-Grade Human Papillomavirus (HPV)-related Cervical Lesions
March 20, 2023
From
Vaccitech plc
Via
GlobeNewswire
Tickers
VACC
Vaccitech Appoints Industry Veteran, Nadège Pelletier, Ph.D., as Chief Scientific Officer
January 30, 2023
From
Vaccitech plc
Via
GlobeNewswire
Tickers
VACC
Vaccitech Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
November 10, 2022
From
Vaccitech plc
Via
GlobeNewswire
Tickers
VACC
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.